igf-1 lr3 clinical trial humans human protein 1000 µg Human E. coli IGF1 LR3-1MG - NewBioRx
Description
The evidence presented clearly demonstrates that exposure to PET MNPs can elicit significant and diverse adverse effects on neurological function and behaviour across multiple animal models
Analysis of in Vitro Aptamer Selection Parameters
Herring P
(2012) 142:126473.e1
Oncotarget 7 , 1175611769 (2016)
